Michael Mian

6PUBLICATIONS
45CO-AUTHORS
Epidemiological methodsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)HaematologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 17, 2024
Indicators of cure for women living after uterine and ovarian cancers: a population-based study.

Fabiola Giudici, Angela De Paoli, Federica Toffolutti

|Mar 23, 2024
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.

Luigino Dal Maso, Federica Toffolutti, Angela De Paoli

|Jul 08, 2021
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term.

Sergio Cortelazzo, Michael Mian, Andrea Evangelista

|May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.

Patrizia Mondello, Caterina Musolino, Irene Dogliotti

|Nov 28, 2018
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib.

Michael Mian, Norbert Pescosta, Stefania Badiali

|Jan 11, 2018
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.

Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher

Pageof 1

Frequent Collaborators

2 joint publications

Lauro Bucchi

2 joint publications

Antonino Musolino

2 joint publications

Roberta De Angelis

2 joint publications

Adele Caldarella